Abstract
Liver dysfunction is a common problem in BMT recipients and it is important to determine the etiology in order to institute appropriate therapy. The purpose of this study was to evaluate the possible causes of liver dysfunction during the first post-transplant year in BMT recipients and to identify a possible relationship between pre-existing liver dysfunction and viral hepatitis with prognosis after BMT. We reviewed liver status before and after BMT in 130 consecutive patients at the Catholic Hematopoietic Stem Cell Transplantation Center. Liver dysfunction during the first post-transplant year occurred in 85 out of 101 (84.2%) allogeneic BMT recipients and 13 out of 29 (44.8%) autologous BMT recipients. In allogeneic BMT, GVHD and drug hepatotoxicity were major causes. In autologous BMT, drug hepatotoxicity was the most common cause. Eighteen out of 130 patients (13.8%) had abnormal liver function tests before BMT. These patients did not have an increased risk of post-transplant liver dysfunction, GVHD, and death compared to patients who had normal liver function tests prior to BMT. Nine patients were hepatitis B antigen positive and three patients were anti-HCV positive prior to BMT. There was no significant increase in the incidence of post-transplant liver dysfunction, GVHD, and death in these patients. Bone Marrow Transplantation (2000) 26, 193–197.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McDonald GB, Shulman HM, Wolford JL, Spencer GD . Liver disease after human marrow transplantation Sem Liver Dis 1987 7: 210–229
Forbes GM, Davies JM, Herrmann RP, Collins BJ . Liver disease complicating bone marrow transplantation: a clinical audit J Gastroenterol Hepatol 1995 10: 1–7
Farthing MJ, Clark ML, Sloane JP et al. Liver disease after bone marrow transplantation Gut 1982 23: 465–474
Ahn YO, Kim YS, Lee MS, Shin MH . Hepatitis B virus infection rate among Koreans Seoul J Med 1992 33: 105–114
Chen PM, Fan S, Hsieh RK et al. Liver disease in patients with liver dysfunction prior to bone marrow transplantation Bone Marrow Transplant 1992 9: 415–419
Locasciulli A, Testa M, Valsecchi MG et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study Blood 1997 90: 3799–3805
Chen PM, Liu JH, Fan FS et al. Liver disease after bone marrow transplantation – the Taiwan experience Transplantation 1995 59: 1139–1143
Lau GK, Liang R, Chiu EK et al. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study Bone Marrow Transplant 1997 19: 795–799
Reed EC, Myerson D, Corey L, Meyers JD . Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen Blood 1991 77: 195–200
Norol F, Roche B, Girardin MF et al. Hepatitis C virus infection and allogeneic bone marrow transplantation Transplantation 1994 57: 393–397
Jones RJ, Lee KSK, Beschorner WE et al. Venocclusive disease of the liver following bone marrow transplantation Transplantation 1987 44: 778–783
McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 118: 255–267
Atkinson K . Chronic graft-versus-host disease Bone Marrow Transplant 1990 5: 69–82
Iqbal M, Creger FJ, Fox RM et al. Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management Bone Marrow Transplant 1996 17: 655–662
Deeg HJ, Shulman HM, Schmidt E et al. Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine Transplantation 1986 42: 497–501
Loucasciulli A, Bacigalupo A, Van Lint MT et al. Hepatitis B virus infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases Bone Marrow Transplant 1990 6: 25–29
Webster A, Brenner MK, Prentice HG, Griffiths PD . Fatal hepatitis B reactivation after autologous bone marrow transplantation Bone Marrow Transplant 1989 4: 207–208
Storb R, Prentice RL, Hansen JA, Thomas ED . Association between HLA-B antigens and acute graft-versus-host disease Lancet 1983 2: 816–819
Snover DC, Weisdorf SA, Ramsay NK et al. Hepatic graft-versus-host disease: a study of the predictive value of liver biopsy in diagnosis Hepatology 1984 4: 123–130
Acknowledgements
Catholic Research Institute of Medical Science Grant 1998 supported this study.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, B., Chung, K., Sun, H. et al. Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study. Bone Marrow Transplant 26, 193–197 (2000). https://doi.org/10.1038/sj.bmt.1702453
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702453
Keywords
This article is cited by
-
Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience
Journal of the Egyptian National Cancer Institute (2020)
-
Development of a novel histologic diagnostic algorithm for hepatic graft-versus-host disease
Modern Pathology (2018)
-
Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children
Pediatric Nephrology (2014)
-
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT
Bone Marrow Transplantation (2010)
-
Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome
Bone Marrow Transplantation (2009)